CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,131,501 shares; 2025Q1: 1,131,501 shares; 2025Q2: 1,131,501 shares; 2025Q3: 1,131,501 shares; 2025Q4: 1,131,501 shares; 2026Q1: 1,130,501 shares; 2026Q2: 1,131,500 shares; 2026Q3: 1,131,500 shares 1,131,500 $80.2M 22.04% 0 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,516,303 shares; 2025Q1: 1,516,303 shares; 2025Q2: 1,259,749 shares; 2025Q3: 1,259,749 shares; 2025Q4: 1,448,420 shares; 2026Q1: 1,673,420 shares; 2026Q2: 1,673,420 shares; 2026Q3: 1,648,420 shares 1,648,420 $67M 18.4% -25,000 Timeline PBYI PUMA BIOTECHNOLOGY INC More: the full row for PUMA BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,940,052 shares; 2025Q1: 3,940,052 shares; 2025Q2: 4,131,299 shares; 2025Q3: 4,131,299 shares; 2025Q4: 4,131,299 shares; 2026Q1: 4,131,299 shares; 2026Q2: 4,131,299 shares; 2026Q3: 4,131,299 shares 4,131,299 $41M 11.27% 0 Timeline CADL CANDEL THERAPEUTICS INC More: the full row for CANDEL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,939,644 shares; 2025Q1: 2,152,252 shares; 2025Q2: 2,580,517 shares; 2025Q3: 2,580,517 shares; 2025Q4: 2,580,517 shares; 2026Q1: 3,497,948 shares; 2026Q2: 3,497,948 shares; 2026Q3: 3,497,948 shares 3,497,948 $36.5M 10.03% 0 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,001,048 shares; 2025Q1: 2,144,844 shares; 2025Q2: 2,144,844 shares; 2025Q3: 2,144,844 shares; 2025Q4: 2,144,844 shares; 2026Q1: 2,144,844 shares; 2026Q2: 2,144,844 shares; 2026Q3: 2,144,844 shares 2,144,844 $30.7M 8.44% 0 Timeline HELP CYBIN INC More: the full row for CYBIN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 734,393 shares; 2025Q1: 734,394 shares; 2025Q2: 734,394 shares; 2025Q3: 734,394 shares; 2025Q4: 1,573,023 shares; 2026Q1: 1,540,266 shares; 2026Q2: 1,540,266 shares; 2026Q3: 1,540,266 shares 1,540,266 $18.9M 5.2% 0 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 786,760 shares; 2026Q2: 986,760 shares; 2026Q3: 986,760 shares 986,760 $13.9M 3.81% 0 Timeline BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 643,381 shares; 2025Q1: 643,382 shares; 2025Q2: 643,382 shares; 2025Q3: 643,382 shares; 2025Q4: 643,382 shares; 2026Q1: 643,382 shares; 2026Q2: 643,381 shares; 2026Q3: 668,381 shares 668,381 $12.4M 3.42% +25,000 Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 779,498 shares; 2025Q1: 779,498 shares; 2025Q2: 779,498 shares; 2025Q3: 779,498 shares; 2025Q4: 1,469,153 shares; 2026Q1: 1,469,153 shares; 2026Q2: 1,469,153 shares; 2026Q3: 1,469,153 shares 1,469,153 $11.8M 3.25% 0 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,439,674 shares; 2025Q1: 1,439,674 shares; 2025Q2: 2,839,674 shares; 2025Q3: 2,839,674 shares; 2025Q4: 2,839,674 shares; 2026Q1: 2,839,674 shares; 2026Q2: 2,839,674 shares; 2026Q3: 2,839,674 shares 2,839,674 $7.75M 2.13% 0 Timeline ENGN ENGENE THERAPEUTICS INC More: the full row for ENGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,271,257 shares; 2026Q3: 3,811,782 shares 3,811,782 $7.62M 2.09% +2,540,525 Timeline ANTX AN2 THERAPEUTICS INC More: the full row for AN2 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,300,000 shares 1,300,000 $6.92M 1.9% new Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 590,508 shares; 2025Q2: 595,744 shares; 2025Q3: 595,744 shares; 2025Q4: 595,744 shares; 2026Q1: 595,744 shares; 2026Q2: 929,077 shares; 2026Q3: 1,025,349 shares 1,025,349 $6.44M 1.77% +96,272 Timeline TARA PROTARA THERAPEUTICS INC More: the full row for PROTARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,279,800 shares; 2025Q1: 1,279,800 shares; 2025Q2: 1,752,115 shares; 2025Q3: 1,752,115 shares; 2025Q4: 1,752,115 shares; 2026Q1: 1,752,115 shares; 2026Q2: 1,752,115 shares; 2026Q3: 1,752,115 shares 1,752,115 $5.34M 1.47% 0 Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,136,974 shares 1,136,974 $4.81M 1.32% new Timeline LONA LEONABIO INC More: the full row for LEONABIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 501,739 shares; 2026Q1: 634,539 shares; 2026Q2: 634,539 shares; 2026Q3: 1,144,416 shares 1,144,416 $4.09M 1.12% +509,877 Timeline WHWK WHITEHAWK THERAPEUTICS INC More: the full row for WHITEHAWK THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,147,052 shares; 2025Q1: 1,139,363 shares; 2025Q2: 1,139,363 shares; 2025Q3: 1,139,363 shares; 2025Q4: 1,139,363 shares; 2026Q1: 1,139,363 shares; 2026Q2: 1,139,363 shares; 2026Q3: 932,139 shares 932,139 $3.5M 0.96% -207,224 Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 803,425 shares; 2025Q1: 803,425 shares; 2025Q2: 803,425 shares; 2025Q3: 803,425 shares; 2025Q4: 493,425 shares; 2026Q1: 315,052 shares; 2026Q2: 216,171 shares; 2026Q3: 216,171 shares 216,171 $1.79M 0.49% 0 Timeline KPTI KARYOPHARM THERAPEUTICS INC More: the full row for KARYOPHARM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 287,826 shares; 2026Q2: 1,518,113 shares; 2026Q3: 1,222,019 shares 1,222,019 $1.49M 0.41% -296,094 Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,382,640 shares; 2025Q4: 1,786,492 shares; 2026Q1: 1,411,492 shares; 2026Q2: 1,438,159 shares; 2026Q3: 1,438,159 shares 1,438,159 $834K 0.23% 0 Timeline VYNE VYNE THERAPEUTICS INC More: the full row for VYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 456,970 shares; 2025Q1: 785,938 shares; 2025Q2: 736,572 shares; 2025Q3: 586,572 shares; 2025Q4: 1,425 shares; 2026Q1: 1,425 shares; 2026Q2: 1,425 shares; 2026Q3: 32,005 shares 32,005 $721K 0.2% +30,580 Timeline BCAB BIOATLA INC More: the full row for BIOATLA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,032,046 shares; 2025Q1: 4,032,046 shares; 2025Q2: 4,835,111 shares; 2025Q3: 4,835,111 shares; 2025Q4: 4,835,111 shares; 2026Q1: 5,406,345 shares; 2026Q2: 108,126 shares; 2026Q3: 108,127 shares 108,127 $141K 0.04% +1 Timeline